To sum up, targeting the Nrf2/HO-1 pathway in the intestine is closely related to ferroptosis in IBD, especially in UC, but there is little research on Crohn’s disease, and more experimental basic research is needed to support it (Figure 3c). Here, NFE2L2 is linked to inflammatory bowel disease.